Rankings
▼
Calendar
ARQT FY 2022 Earnings — Arcutis Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ARQT
Arcutis Biotherapeutics, Inc.
$3B
FY 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$4M
Gross Profit
$3M
79.5% margin
Operating Income
-$302M
-8183.0% margin
Net Income
-$311M
-8449.8% margin
EPS (Diluted)
$-5.66
Cash Flow
Operating Cash Flow
-$258M
Free Cash Flow
-$281M
Stock-Based Comp.
$33M
Balance Sheet
Total Assets
$449M
Total Liabilities
$240M
Stockholders' Equity
$210M
Cash & Equivalents
$54M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4M
$0
—
Gross Profit
$3M
-$763,000
+484.3%
Operating Income
-$302M
-$207M
-46.0%
Net Income
-$311M
-$206M
-50.9%
← Q4 2021
All Quarters
Q1 2022 →